The Unyvero platform developed by Curetis is a fast, comprehensive diagnostics system for severe infectious diseases in hospitalized patients.
Using a variety of cartridges, diseases such as pneumonia or implant and tissue infections can be easily and rapidly diagnosed within just four to five hours, whether this is in the laboratory or directly at the "point of need" in the hospital.
Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test
Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
Reanimation Congress 2019 - Paris, France - 23 to 25 January, 2019
29. Symposium Intensivmedizin + Intensivpflege - Bremen, Germany - 20 to 22 February, 2019